Oncolytic herpes simplex virus mutants are more efficacious than wild-type adenovirus Type 5 for the treatment of high-risk neuroblastomas in preclinical models.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples